Related Experiment Video
Updated: Mar 24, 2026

06:09
Quantification of Tumor Cell Adhesion in Lymph Node Cryosections
Published on: February 9, 2020
13.7K
Risk factors for persistent disease in papillary thyroid carcinoma with lymph node metastasis
Aylin Oral1, Bulent Yazici, Aysegül Akgün
1Departments of aNuclear Medicine bPublic Health, Ege University Medical Faculty, Izmir, Turkey.
Nuclear Medicine Communications
|March 12, 2016
Summary
Papillary thyroid carcinoma (PTC) patients with lymph node (LN) metastasis can achieve disease-free status with therapy. However, older age, extrathyroidal invasion, and lateral cervical LN metastasis predict persistent disease.
Area of Science:
- Oncology
- Endocrinology
- Head and Neck Surgery
Background:
- Neck lymph node (LN) metastasis is a known correlate of persistent disease in papillary thyroid carcinoma (PTC).
- While many PTC patients achieve remission post-therapy, a subset experiences persistent disease.
- Identifying factors influencing disease course in PTC with LN metastasis is crucial for tailored management.
Purpose of the Study:
- To determine variables affecting the clinical course of PTC.
- To identify patterns of persistent disease in PTC patients with LN metastasis.
- To pinpoint risk factors for persistent disease in this patient cohort.
Main Methods:
- Analysis of clinicopathological characteristics and persistent disease patterns in PTC patients with LN metastasis.
- Univariate and multivariate analyses were employed to identify risk factors.
- Median follow-up duration was 84 months.
Main Results:
- 69% of patients achieved disease-free status; 31% had persistent disease.
- Univariate analysis identified male sex, age ≥45, tumor size >4 cm, lateral cervical LN metastasis, extrathyroidal invasion, and ≥10 metastatic LNs as predictors.
- Multivariate analysis revealed extrathyroidal involvement, lateral cervical LN metastasis, and age ≥45 as independent predictors.
Conclusions:
- Most PTC patients with LN involvement achieve disease-free status with therapy.
- Extrathyroidal invasion, lateral cervical LN involvement, and age ≥45 at diagnosis are associated with higher likelihood of persistent disease.
- Close clinical follow-up and appropriate therapy can lead to disease control.

